Emily Siu Clausen, MD
Assistant Professor of Clinical Medicine
Department: Medicine
Contact information
Hospital of the University of Pennsylvania
Philadelpha, PA 19104
Philadelpha, PA 19104
Education:
BA
University of Louisville, Kentucky, 2007.
MD (Medicine)
University of North Carolina-Chapel Hill, 2011.
Permanent linkBA
University of Louisville, Kentucky, 2007.
MD (Medicine)
University of North Carolina-Chapel Hill, 2011.
Description of Clinical Expertise
Medical Monitor for Clinical Trials1) Study of Clinical Efficacy of Antimicrobial Therapy Strategy Using Pragmatic Design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF)
Clinical Events Classification Committees
1) A Phase 3b/4 Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with Exenatide Once Weekly in
Patients with Type 2 Diabetes Mellitus (The EXSCEL Trial)
2) Anemia Studies in CKD: Erythropoiesis via a Novel PHI Daprodustat-Dialysis (ASCEND-D)
3) Anemia Studies in CKD: Erythropoiesis via a Novel PHI Daprodustat-Non- Dialysis (ASCEND-ND)
4) Anemia Studies in CKD: Erythropoiesis via a Novel PHI Daprodustat-in Incident Dialysis (ASCEND-ID)
Selected Publications
Hadjiliadis D, Clausen ES.: A new era has dawned for persons with cystic fibrosis; however many knowledge gaps exist in our efforts to improve care. J Cyst Fibros 2022.Clausen ES, Weber JM, Ramos KJ, Snyder LD.: Survival difference between high-risk and low-risk CFTR genotypes after lung transplant. J Heart Lung Transplant 2022.
Courtwright A, Kamoun M, Diamond J, Kearns J, Ahya V, Christie J, Clausen E, Hadjiliadis D, Patel N, Salgado J, Cevasco M, Cantu E, Crespo M, Bermudez C: Lung transplantation outcomes after crossing low-level donor specific antibodies without planned augmented immunosuppression Clin Transplant 35(11): e14447, Nov 2021.
Criner R, Clausen E, Cantu E: Primary Graft Dysfunction Curr Opin Organ Transplant 26(3): 321-327, June 2021.
Safirstein J, Grant J, Clausen E, Savant D, Dezube R, Hong G: Biliary disease and cholecystectomy after initiation of elexacaftor/ivacaftor/tezacaftor in adults with cystic fibrosis. J Cyst Fibros 20(3): 506-510, May 2021.
Clausen ES, Hadjiliadis D.: Age at Lung Transplant Impacts Post-Transplant Survival in Cystic Fibrosis; Why? Ann Am Thorac Soc 2021.
Clausen E and Zaffiri L.: Infection prophylaxis and management of viral infection. Ann Transl Med 8(6): 415, Mar 2020.
Anstrom KJ, Noth I, Flaherty KR, Edwards RH, Albright J, Baucom A, Brooks M, Clark AB, Clausen E, Durheim MT, Kim D, Kirchner J, Oldham J, Snyder LD, Wilson AM, Wisniewski SR, Yow E, Martinez FJ, CleanUP-IPF Study Team: Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial. Respir Res 21(68): published on line, Mar 2020.
Clausen ES, Frankel C, Palmer SM, Snyder LD, Smith PJ: Pre-transplant weight loss and clinical outcomes after lung transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 37(12): 1443-1447, Dec 2018.
Qin S, Clausen E, Nouraie SM, Kingsley L, McMahon D, Kleerup E, Huang L, Ghedin E, Greenblatt RM, Morris A: Tropheryma whipplei colonization in HIV-infected individuals is not associated with lung function or inflammation. PloS one 13(10): e0205065, Oct 2018.